Propanc Biopharma, Inc. Common Stock (PPCB) — Cash Flow-to-Debt Ratio
Propanc Biopharma, Inc. Common Stock (PPCB) has a Cash Flow-to-Debt Ratio of -0.25x as of March 2026, meaning its operating cash flow of $-1.14 Million could theoretically repay 0% of its total liabilities ($4.51 Million) in one year. See financial flexibility index of Propanc Biopharma, Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Propanc Biopharma, Inc. Common Stock Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Propanc Biopharma, Inc. Common Stock across 16 annual periods. For the full cash flow conversion analysis, see PPCB cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Propanc Biopharma, Inc. Common Stock (2010–2025)
Year-by-year debt coverage analysis for Propanc Biopharma, Inc. Common Stock. Check PPCB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | $-405.17K | $5.73 Million | ▲ +70.9% |
| 2024 | -0.24x | $-935.12K | $3.85 Million | ▲ +30.2% |
| 2023 | -0.35x | $-1.11 Million | $3.18 Million | ▲ +24.8% |
| 2022 | -0.46x | $-1.44 Million | $3.11 Million | ▼ -24.4% |
| 2021 | -0.37x | $-1.15 Million | $3.08 Million | ▲ +24.8% |
| 2020 | -0.49x | $-1.85 Million | $3.74 Million | ▼ -5.7% |
| 2019 | -0.47x | $-2.06 Million | $4.40 Million | ▼ -46.6% |
| 2018 | -0.32x | $-2.18 Million | $6.82 Million | ▲ +17.9% |
| 2017 | -0.39x | $-2.15 Million | $5.54 Million | ▲ +76.2% |
| 2016 | -1.63x | $-4.80 Million | $2.94 Million | ▼ -320.6% |
| 2015 | -0.39x | $-1.43 Million | $3.68 Million | ▼ -160.5% |
| 2014 | -0.15x | $-226.44K | $1.52 Million | ▲ +8.2% |
| 2013 | -0.16x | $-128.65K | $794.22K | ▲ +44.4% |
| 2012 | -0.29x | $-170.28K | $584.19K | ▲ +93.6% |
| 2011 | -4.55x | $-1.40 Million | $306.85K | ▼ -448.0% |
| 2010 | -0.83x | $-191.51K | $230.76K | — |